GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pak Fah Yeow International Ltd (HKSE:00239) » Definitions » Capex-to-Operating-Cash-Flow

Pak Fah Yeow International (HKSE:00239) Capex-to-Operating-Cash-Flow : 0.00 (As of Dec. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Pak Fah Yeow International Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Pak Fah Yeow International's Capital Expenditure for the six months ended in Dec. 2024 was HK$-0.47 Mil. Its Cash Flow from Operations for the six months ended in Dec. 2024 was HK$-9.23 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


Pak Fah Yeow International Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Pak Fah Yeow International's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pak Fah Yeow International Capex-to-Operating-Cash-Flow Chart

Pak Fah Yeow International Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.01 - 0.02 0.01

Pak Fah Yeow International Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.01 0.03 0.01 -

Competitive Comparison of Pak Fah Yeow International's Capex-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Pak Fah Yeow International's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pak Fah Yeow International's Capex-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pak Fah Yeow International's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Pak Fah Yeow International's Capex-to-Operating-Cash-Flow falls into.


;
;

Pak Fah Yeow International Capex-to-Operating-Cash-Flow Calculation

Pak Fah Yeow International's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-0.937) / 78.956
=0.01

Pak Fah Yeow International's Capex-to-Operating-Cash-Flow for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-0.469) / -9.225
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pak Fah Yeow International  (HKSE:00239) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Pak Fah Yeow International Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Pak Fah Yeow International's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Pak Fah Yeow International Business Description

Traded in Other Exchanges
N/A
Address
200 Gloucester Road, 11th Floor, Wanchai, Hong Kong, HKG
Pak Fah Yeow International Ltd, with its subsidiaries, is engaged in the manufacture and distribution of healthcare products, including Hoe Hin branded products. It also engages in real estate investment and treasury investment businesses. It has three business segments, namely healthcare, property investments, and treasury investments. The Company derives the majority of its revenues from the Healthcare segment. The Group's operates in Hong Kong, Macau, other regions in the People's Republic of China (the PRC or Mainland China), Southeast Asia, North America and the United Kingdom.
Executives
Gan Fock Wai Stephen 2101 Beneficial owner
Brooke Jonathan William 2101 Beneficial owner

Pak Fah Yeow International Headlines

No Headlines